Linezolid Pfizer 20 mg/ml, Granulat zur Herstellung einer Suspension zum Einnehmen

7680662500013 CH-66250 Granulat
Linezolid Pfizer 20 mg/ml, Granulat zur Herstellung einer Suspension zum Einnehmen
Linezolid Pfizer 20 mg/ml, Granulat zur Herstellung einer Suspension zum Einnehmen
Linezolid Pfizer 20 mg/ml, Granulat zur Herstellung einer Suspension zum Einnehmen
1 / 3
google

Article details

Package size
150
Selling units
150
Measure
ml
Galenic form
Granulat
Galenic group
Lösbar zur Einnahme

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
27/02/2024
Patient information leaflet
Français
27/02/2024
Patient information leaflet
Italien
27/02/2024
Summary of Product Characteristics
Allemand
27/02/2024
Summary of Product Characteristics
Français
27/02/2024
Summary of Product Characteristics
Italien
27/02/2024

Detailed composition

Substance Quantity Type Category
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
210.58 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
7.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
2.0 MG Substance HBESI
(N/A)
- Substance AROMA
(N/A)
0.2 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance AROMA
(N/A)
- Substance AROMA
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
8.76 MG Substance HBESI
(N/A)
3.36 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance AROMA
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
2.279 MG Substance HBESI

Reimbursement information

Public price
CHF 254.80
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/11/2016

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
66250
Drug name
Linezolid Pfizer, Granulat zur Herstellung einer Suspension zum Einnehmen
Galenic form
GRAS
ATC Code
J01XX08
Authorization status
Z
Authorization category
Category C
Dispensing category
A
First authorization
09/06/2016
Authorization expiration date
31/12/9999
IT Number
08.01.9.
Domain
Human medicine
Field of application
Infektionskrankheiten

Package details

Description (FR)
LINEZOLID Pfizer gran 20 mg/ml p susp fl 150 ml
Description (DE)
LINEZOLID Pfizer Gran 20 mg/ml f Susp Fl 150 ml
Market launch
09/06/2016
Narcotic (BTM)
No

Original drug

Zyvoxid 20 mg/ml, Granulat zur Herstellung einer Suspension zum Einnehmen
GTIN: 7680555590022
CHF 279.75
View original